Clinical Trial Update: Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial of intramuscular paliperidone palmitate injections in the arm or buttock for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED